Apheresis Procedure

PROCEDURE3 trials

Sponsors

H. Lee Moffitt Cancer Center and Research Institute, M.D. Anderson Cancer Center, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Conditions

Blood And Marrow TransplantationMelanoma (Skin)Optimize PBSC Harvest Through Automated Buffy Coat

Phase 1

Vaccine Combining Multiple Class I Peptides and Montanide ISA 51VG With Escalating Doses of Anti-PD-1 Antibody Nivolumab or Ipilimumab With Nivolumab For Patients With Resected Stages IIIC/ IV Melanoma

CompletedNCT01176474

H. Lee Moffitt Cancer Center and Research InstituteMelanoma (Skin)

Start: 2010-08-13End: 2023-01-06Updated: 2023-07-19

Phase 2

Plerixafor for Stem Cell Mobilization in Normal Donors

CompletedNCT01818284

M.D. Anderson Cancer CenterBlood And Marrow Transplantation

Start: 2013-10-31End: 2016-06-30Updated: 2019-04-23

Unknown Phase

Biological Variables Affecting CD34+ Peripheral Cells Collection Efficiency

CompletedNCT06308133

Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOptimize PBSC Harvest Through Automated Buffy Coat

Start: 2023-09-01End: 2023-12-31Updated: 2024-03-13

Related Papers

Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma

Journal for ImmunoTherapy of Cancer2022-11-017 citations

Adjuvant nivolumab (NIVO) plus ipilimumab (IPI) for resected high-risk stages IIIC/IV melanoma (MEL).

Journal of Clinical Oncology2016-05-2010 citations